RE:YOUTH Introduction

RE:YOUTH Introduction

RE:YOUTH

is a specialized foreign patient treatment organization in Korea.

We are enabling patients with incurable diseases around the world to enjoy a second life through arterial stem cell treatment, Korea’s advanced medical technology.

Only through RE:YOUTH in Korea can you receive guidance on stem cell treatment through the artery, which is the only treatment method in the world.

A clear reason why stem cell transplants

should be performed in
arteries rather than veins

Arterial stem cell transplantation into the blood vessels
of a specific organ is a treatment that can be difficult to find
anywhere in the world, and is only available through RE:YOUTH.

Existing stem cell treatment

Stem cell extraction from venous blood
(Oxygen saturation ↓, Nutrients ↓, Waste ↑)​

Injecting stem cells into a vein
(About 80% of stem cells are lost in the lungs)

Compared to cardiac output, very few stem
cells are injected into specific body organs.

(e.g. when injecting stem cells to treat brain disease)

❶ When 1 billion cells are injected, 800 million cells are lost from the lungs.

❷ Of the 200 million cells, only 40 million cells, which is 20% of cerebral blood flow compared to cardiac output, are injected into the brain.

❸ In the end, out of 1 billion cells, only 40 million stem cells that go to the brain are injected.

Selective Stem Cell Injection Organs: Not clearly defined

RE:YOUTH’s new stem cell treatment

Stem cell extraction from arterial blood
(Oxygen saturation ↑, Nutrients ↑, Waste ↓)​

Stem cell extraction from arterial blood
(Oxygen saturation ↑, Nutrients ↑, Waste ↓)​

Injecting stem cells into arteries
(100% injection of necessary organs possible)

Regardless of the amount of blood flowing to a specific body
organ compared to cardiac output, 100% of the injected stem cells can be injected into target organs.

(e.g. when injecting stem cells to treat brain disease)

❶ When 1 billion cells are injected, all 1 billion cells can be directly injected into the brain through cerebral blood vessels.

❷ In other words, there is a difference (25 times) in the effect of stem cell injection compared to intravenous stem cell injection.

100% selective injection of stem cells into required organs is possible

From airport pick-up for foreign patients visiting Korea, Accommodation guidance, Hospital guidance on the day of the procedure, Touring Korea guidance upon patient request after recovery, Airport sending upon return to their countries and After-care

RE:YOUTH will become a pioneer in the global medical industry and medical tourism
with the world's only stem cell treatment.

World-class arterial stem cell treatment

A pioneer in the global medical industry

VIP medical tourism and health care

Introduction to the director of stem cell treatment

Journey of
More than 30 years..

The process of finding better treatments through countless planning, implementation, and review of how to achieve safer and better results during endovascular procedures has been a long journey of over 30 years.

While working as a professor at Sinchon Severance Hospital and a university, I performed more than 45,000 vascular examinations and 10,000 endovascular procedures. In the process, I researched the first surgical methods in Korea and presented them at various academic conferences at home and abroad, which are now common at home and abroad. It has become a treatment administered as a treatment.

This entire process is based on a sincere thought for the patient: “How can we provide better results to even just one more patient?” and “How can we provide more effective treatment to even just one new patient?” It was the result of .

We at Yonsei BH Clinic will continue to lead in areas where no one else has been able to. We will give new hope to patients with incurable diseases who have been ignored because they cannot be cured.

The Director of Yonsei BH Clinic

Director: Dr. Lee Byung-hee

Profile

  • Graduated from Yonsei University College of Medicine
  • Intern and Resident at Severance Hospital
  • Fellowship at Severance Hospital
  • Assistant Professor at Bundang CHA Hospital
  • Professor at Eulji University Hospital
  • Director of the Cerebrovascular Center at Cheonan Chungmu Hospital
  • First in Korea to perform carotid artery stenting (1997)
  • First in Korea to perform intracranial cerebrovascular stenting (1998)
  • Invited lecturer at the founding celebration of the Korean Stroke Society (2000)
  • First in Korea to perform stent-assisted platinum coil embolization for cerebral aneurysms (2002)
  • Academic Activities

Academic Activities

  • Regular Member of the Korean Society of Radiology
  • Founding Member of the Korean Society of Neurointervention
  • Founding Member of the Korean Stroke Society
  • Regular Member of the American Stroke Association
  • Regular Member of the World Stroke Organization
  • Regular Member of the World Society of Interventional Neurology
  • Regular Member of the European Society of Interventional Neurology
  • Regular Member of the Interventional Society
  • Published 24 papers in home and abroad journals (SCI)
  • Delivered 50 lectures and presentations in home and abroad
  • Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease. J Korean Neurosurg Soc 2011 July;50:40-44
  • Reconstructive endovascular treatment of ruptured blood blister-like aneurysms of the internal carotid artery. 2009 Journal of Neurosurgery 110(3):431-6
  • Various technical approaches for endovascular treatment of ugly aneurysm. J Korean Society of Intravascular Neurosurgery 2008 Oct;3:24-33
  • Blister-like aneurysms of the supraclinoid internal carotid artery: Challenging endovascular treatment with stent-assisted coiling. Journal of Clinical Neuroscience 2008 15(9):1058-61
  • Pre-operative embolisation of internal carotid artery branches and pial vessels in hypervascular tumours. Acta Neurochirurgica(Wien) 2008 150(5):447-52
  • Cognitive dysfunction in 16 patients with carotid stenosis: detailed neuropsychological findings. Journal of Clinical Neurology 2007 March;3(1):9-17
  • Endovascular treatment of intracranial vertebral artery dissections with stents placement or stent-assisted coiling. Am J Neuroradiol 2006 Aug;27:1514-20
  • Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis. Am J Neuroradiol 2005;26:1381-88
  • Techniques for intracranial stent navigation in patients with tortuous vessel. Am J Neuroradiol 2005;26:1375-80
  • Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. Am J Neuroradiol 2005;26:166-174
  • Treatment of spontaneous arterial dissection with stent placement for preservation of the parent artery. Acta Neurochir(Wien) 2005;147(3):265-73
  • Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischemic deficits or stroke attacks:Short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004;75:847-851